Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab.

Yoshiaki Yamamoto,Hideyasu Matsuyama,Hiroaki Matsumoto,Shigeru Sakano,Nakanori Fujii,Kazuo Oba,Mitsutaka Yamamoto,Yoriaki Kamiryo,T Hiragino,Kazuhiro Nagao,Kimio Takai,Akihiko Aoki,Satoru Yoshihiro,Manabu Tsukamoto,Jumpei Akao,Seiji Kitahara,Taku Misumi,Hirotaka Komatsu,Shintaro Oka,Akinobu Suga

Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab.

2020

724Background: Nivolumab is a standard treatment for previously treated advanced renal-cell carcinoma (RCC). However, nivolumab is effective in only a limited number of patients; therefore, we eval...

Keywords:

Oncology
Standard treatment
Pathology
Nivolumab
Renal cell carcinoma
Carcinoma
Internal medicine
Medicine
risk stratification
previously treated

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations